Purple Biotech (PPBT)
(Delayed Data from NSDQ)
$3.11 USD
-0.10 (-3.12%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $3.12 +0.01 (0.32%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/19/2024
Time: -- |
9/2024 | $-1.20 | 0.00% |
Earnings Summary
For their last quarter, Purple Biotech (PPBT) reported earnings of -$1.60 per share, beating the Zacks Consensus Estimate of $-2.60 per share. This reflects a positive earnings surprise of 38.46%. Look out for PPBT's next earnings release expected on November 19, 2024. For the next earning release, we expect the company to report earnings of -$1.20 per share, reflecting a year-over-year increase of 71.43%.
Earnings History
Price & Consensus
Zacks News for PPBT
Here's Why Purple Biotech Ltd. Sponsored ADR (PPBT) Could be Great Choice for a Bottom Fisher
PPBT: What are Zacks experts saying now?
Zacks Private Portfolio Services